BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 14261407)

  • 1. METABOLISM OF ANTIDIABETIC SULFONYLUREAS IN MAN. I. BIOLOGICAL HALF-LIVES OF THE P-ACETYLBENZENESULFONYLUREAS, U-18536 AND ACETOHEXAMIDE AND THEIR METABOLITES.
    SMITH DL; VECCHIO TJ; FORIST AA
    Metabolism; 1965 Mar; 14():229-40. PubMed ID: 14261407
    [No Abstract]   [Full Text] [Related]  

  • 2. SERUM CONCENTRATION AND URINARY EXCRETION OF ORAL SULFONYLUREA COMPOUNDS: RELATION TO DIABETIC CONTROL.
    SHELDON J; ANDERSON J; STONER L
    Diabetes; 1965 Jun; 14():362-7. PubMed ID: 14298920
    [No Abstract]   [Full Text] [Related]  

  • 3. [ACTION OF HYPOGLYCEMIC SULFONAMIDES ON THE PRODUCTION OF CO2 BY ADIPOSE TISSUE OF THE RAT EPIDIDYMIS "IN VITRO"].
    MARQUES M; RIETCORREA P
    Folia Endocrinol; 1964 Jun; 17():381-6. PubMed ID: 14210726
    [No Abstract]   [Full Text] [Related]  

  • 4. A quantum chemical study with special reference to the sulfamyl group of sulfonylureas.
    Orita Y; Ando A; Takamitsu Y; Urakabe S; Shirai D
    Jpn Circ J; 1970 Sep; 34(9):775-8. PubMed ID: 5537674
    [No Abstract]   [Full Text] [Related]  

  • 5. TWO YEARS' EXPERIENCE WITH ACETOHEXAMIDE.
    LOZANO CASTANEDA O; CAMERINI D AVALOS RA; KRALL LP; MARBLE A
    Metabolism; 1964 Feb; 13():99-106. PubMed ID: 14127093
    [No Abstract]   [Full Text] [Related]  

  • 6. Acetohexamide: comparison with other sulfonylurea compounds in the treatment of diabetes mellitus.
    BOSHELL BR; WILENSKY AS; BARRETT JC; ALMON JV
    Clin Pharmacol Ther; 1962; 3():750-7. PubMed ID: 14014164
    [No Abstract]   [Full Text] [Related]  

  • 7. [ON TOLAZAMIDE: APROPOS OF A NEW HYPOGLYCEMIC SULFANYLUREA AND OF ACQUIRED SULFANYLUREAU RESISTANCE].
    KLINGER R; DALLECOSTE P
    Minerva Med; 1964 Jul; 55():2237-40. PubMed ID: 14179829
    [No Abstract]   [Full Text] [Related]  

  • 8. CLINICAL EFFECTS OF A NEW, POTENT, NON-TOXIC SULFONYLUREA (TOLAZAMIDE).
    GRINNELL EH; SKILLMAN TG; BARSE R; MOLLER CL
    Curr Ther Res Clin Exp; 1964 Jul; 6():433-41. PubMed ID: 14203273
    [No Abstract]   [Full Text] [Related]  

  • 9. The pharmacology of sulfonylureas.
    Skillman TG; Feldman JM
    Am J Med; 1981 Feb; 70(2):361-72. PubMed ID: 6781341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SEVERE AND PROLONGED HYPOGLYCEMIC SHOCK DURING SULFONYLUREA TREATMENT.
    BAUER HG
    Metabolism; 1965 Mar; 14():220-8. PubMed ID: 14261406
    [No Abstract]   [Full Text] [Related]  

  • 11. USE OF ACETOHEXAMIDE (DYMELOR) IN DIABETIC PATIENTS WITH SECONDARY FAILURES TO ANTIDIABETIC DRUGS.
    GOODMAN JI
    J Indiana State Med Assoc; 1964 Oct; 57():1133-8. PubMed ID: 14199301
    [No Abstract]   [Full Text] [Related]  

  • 12. ACETOHEXAMIDE: CLINICAL EVALUATION OF A NEW ORAL ANTIDIABETIC AGENT.
    ALTERMAN SL; LIEBER AL
    Curr Ther Res Clin Exp; 1964 Mar; 6():148-55. PubMed ID: 14131413
    [No Abstract]   [Full Text] [Related]  

  • 13. ACETOHEXAMIDE ('DIMELOR') IN DIABETES.
    HERMAN M; JACKSON WP
    S Afr Med J; 1964 Jul; 38():519-22. PubMed ID: 14182168
    [No Abstract]   [Full Text] [Related]  

  • 14. ACETOHEXAMIDE--A NEW ORAL AGENT FOR CONTROL OF DIABETES MELLITUS. A PRELIMINARY REPORT.
    FENTRESS V; COOKSEY NJ
    Harper Hosp Bull; 1964; 22():111-4. PubMed ID: 14159417
    [No Abstract]   [Full Text] [Related]  

  • 15. ORAL THERAPY FOR DIABETES MELLITUS.
    WILLIAMS RH
    JAMA; 1965 Sep; 193():829-30. PubMed ID: 14329992
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduction of the severity of nephropathy in aging Fischer 344 rats treated with analogs of arylsulfonyluria.
    Milman HA; Peckham JC; Ward JM; Tarone RE
    Toxicol Appl Pharmacol; 1979 Jul; 49(3):425-30. PubMed ID: 473209
    [No Abstract]   [Full Text] [Related]  

  • 17. [CLINICAL OBSERVATIONS DONE WITH ACETOHEXAMIDE IN THE ORAL TREATMENT OF DIABETES MELLITUS IN THE ADULT].
    PAES E; SILVAGOMES FJ; CANAS MA
    Rev Iber Endocrinol; 1964; 11():5-17. PubMed ID: 14134258
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral treatment in diabetes.
    Stowers JM
    Clin Endocrinol Metab; 1972 Nov; 1(3):721-50. PubMed ID: 4204135
    [No Abstract]   [Full Text] [Related]  

  • 19. ORAL HYPOGLYCEMIC AGENTS.
    THOSTESON GC
    Harper Hosp Bull; 1964; 22():107-10. PubMed ID: 14159416
    [No Abstract]   [Full Text] [Related]  

  • 20. [CLINICAL EXPERIENCES WITH A NEW ORAL HYPOGLYCEMIC DRUG, ACETOHEXAMIDE].
    CHANIS RA
    Arch Med Panamenos; 1963 Dec; 12():193-206. PubMed ID: 14161953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.